Anybody using essaic tea as complementary therapy
Comments
-
Hello
Mother recently diagnosed with Stage iv metastic breast cancer. Starting n Xeloda ...Anyone have experience with Essiac Tea ?
Also looking for a local support group in New Jersey for family members.
Thanks
-
Be careful with these products--there isn't any clinical data that suggests efficacy.
-
You might consider consulting an md who is a holistic practitioner--they tend to be a little more evidence based and might prevent her from coming into contact with any complementary treatment that might be damaging.
-
There hasn't been much scientific research on Essiac, but the little I can find indicates it may promote breast cancer growth rather than prevent or reverse it. Sorry for the small print, can't figure out how to enlarge it. Here's the site for the entire report:
http://www.cbcrp.org/research/PageGrant.asp?grant_id=2101
Evaluation of Essiac Tea to Prevent Mammary Tumors
Lawrence Livermore National LaboratoryOpen Window Investigator(s): Kristen Kulp , Ph.D. - Award Type: Innovative Awards > IDEA Award Cycle: 2001 (Cycle VII)Grant #: 7IB-0003 Award Amount: $185,642 Research PrioritiesPrevention and Risk Reduction > Explaining nutritional pathways for prevention of breast cancer Initial Award Abstract (2001)Breast cancer will be diagnosed in 18,000 Californian women in 2001. Preventing breast cancer, both primary tumors and recurrences, is preferable to treating disease. The purpose of this research is to determine if Essiac tea, a complementary therapy widely self-administered by breast cancer survivors and patients, prevents breast cancer. Complementary therapies are not always discussed with physicians. When alternative approaches are discussed, counseling is hindered by large gaps in knowledge about safety, efficacy, and potential drug interactions. Essiac Tea, an herbal mixture introduced in the 1920's to treat cancer, is commonly used today by breast cancer survivors to try to prevent recurrence. The biological activities of the individual herbs used in one Essiac tea formulation have characteristics associated with decreasing cancer risk. Many herbs used in Essiac tea have long histories of use in Asian diets and medicines. In spite of its potential benefits, Essiac tea is not the subject of any published reports evaluating its efficacy to prevent breast cancer. Because it is widely used, it is important to fill the knowledge gap about the ability of Essiac tea to prevent cancer. The central question addressed by this application is: "To what extent does Essiac tea treatment reduce mammary tumor development in rodents?" The ducts of the mammary gland, through which milk is delivered to the suckling newborn, can be visualized as tree branches. We expect that Essiac exposure will reduce tumors and that this reduction will be associated with changes in the branching pattern of the mammary tree. Two mammalian models (models with mammary glands) will be used to determine if drinking Essiac tea can reduce cancer development. Mammary tumor inhibition by Essiac tea will be studied in rats that are treated with a chemical to induce tumors. This approach is well-described and its use in tumor prevention studies is well-accepted by the scientific community. A mouse model will be used that develops mammary tumors because the Neu oncogene (a cancer gene) is overactive which results in uncontrolled cell growth in the mammary ducts. Thirty percent of breast tumors make too much of the Her-2/Neu cancer protein; patients with this type of breast tumor have lower survival and an increased risk of metastasis than other breast cancer patients. In this study, the number of animals with tumors, the average number of tumors per animal, and the complexity of ductal branching will be compared between Essiac tea treated and untreated animals. This proposal is unique because it will rigorously test Essiac tea for its ability to prevent mammary tumors in well established animal models. In addition to the evaluation of Essiac on tumor development, ductal branching patterns will also be studied. If Essiac tea does not inhibit or increases mammary tumor development, this information could be used to direct patients to other complementary therapies. If mammary tumors are inhibited by Essiac tea, this would open doors to perform studies in cancer survivors to evaluate the ability of Essiac tea to prevent recurrence and to determine how our daughters might benefit from its use with population studies. In addition, studies would be designed to determine how Essiac tea works, what affect it has on the body, and if there are herbal-drug interactions. These studies would be necessary to develop science-based recommendations for its use among Californians. Final Report (2003)Women diagnosed with breast cancer often self-administer complementary and alternative medicine (CAM) to augment conventional treatments, improve health, or prevent recurrence. Approximately 50% of patients using CAM don't inform their physicians and if they do counseling is often hindered by the lack of scientific knowledge about CAM. Breast cancer patients and survivors use herbal tonics like Essiac® and Flor-Essence® Herbal Tonics because of anecdotal evidence that they can treat or prevent disease. Flor-Essence® is a complex mixture of eight herbal extracts. The eight individual herbs have estrogenic, cytotoxic, anti-tumor, anti-mutagenic, anti-oxidant, and anti-inflammatory properties, among others. There have been no scientific studies done to evaluate these herbal tonics in cells, animal models, or clinical trials. This project had two specific aims: To determine if Essiac exposure reduces mammary tumor incidence and/or multiplicity in rats treated with dimethylbenz[a]anthracene (DMBA), a well-recognized mammary gland carcinogen. The DMBA rat model of mammary carcinogenesis is a well accepted model in which to study mammary tumor prevention To determine if Essiac exposure inhibits mammary tumor development in (MMTV)c-neu transgenic mice, a mouse model in which mammary tumors develop spontaneously due to c-neu oncogene over-expression. This model is relevant to humans because patients whose breast tumors overexpress Her-2/Neu have reduced survival and an increased risk of metastasis compared to patients whose tumors do not. Approximately 30% of breast tumors overexpress the Her-2/Neu oncogene We made progress in both aims as follows: Specific Aim 1: This aim has been successfully completed. Female rats were given water or a 3% or 6% solution of Flor-Essence® Herbal Tonic for 23 weeks beginning at one day of age. They were given a single oral dose of DMBA (40 mg/kg body weight) at 7 weeks of age to induce mammary tumors. At the end of the study 82% of the Flor-Essence® treated rats had palpable tumors compared to 71% in the control group. Pysiologically relevant concentraions of Flor-Essence® did not inhibit mammary tumor development but instead appeared to promote it. Specific Aim 2: The animal work for this aim has been completed. (MMTV)c-neu transgenic mice were treated with 3% Flor-Essence® in utero, from birth to weaning, over their lifetime, or not at all to determine if timing of Flor-Essence® exposure had an effect on mammary tumor development in this model. Although the data have not been analyzed for statistical significance, preliminary results suggest that the mice consuming lifetime Flor-Essence® had fewer tumors than the other groups. However the overall survivability of this group suggests that the Flor-Essence® had a negative impact on their health. The results from Specific Aim 1 suggest Flor-Essence® promotes the growth of DMBA-induced rat mammary tumors, although the results from Aim 2 suggest that in some instances some part of this complex mixture may be protective. Women who purchase Flor-Essence® after having been diagnosed with breast cancer use it in hopes that it will cure disease or prevent recurrence. It is important to understand the biologic consequences of self-administration of commercially available CAM on the breast. These studies are necessary for consumers and physicians to make informed decisions about CAM use. Symposium Abstract (2003)Women diagnosed with breast cancer often self-administer complementary and alternative medicine (CAM) to augment conventional treatments, improve health, or prevent recurrence. Physician counseling about the use of these products is often hindered by the lack of scientific knowledge about CAM. Breast cancer patients and survivors use herbal tonics like Essiac® and Flor-Essence® because of anecdotal evidence that the tonics can treat or prevent disease. Essiac® is a combination of four herbal extracts and Flor-Essence® adds four additional extracts to the basic recipe. The individual herbs have estrogenic, cytotoxic, anti-tumor, anti-mutagenic, anti-oxidant, and anti-inflammatory properties, among others. There have been no scientific studies done to evaluate these herbal tonics in cells, animal models, or clinical trials. We are using cellular and animal models to evaluate the consequences of Flor-Essence® and Essiac® exposure on the breast. Cell proliferation assays in estrogen receptor positive (MCF-7) and estrogen receptor negative (MDA-MB-436) breast cancer cells demonstrated that exposures ranging from 1 to 8% Essiac® and Flor-Essence® stimulate growth up to 180% compared to untreated cells. There is no significant difference in growth stimulation between Essiac® and Flor-Essence® in either cell type. In estrogen receptor activation assays, Essiac® and Flor-Essence® stimulate estrogen receptors to levels similar to physiological estrogen and genestein. Flor-Essence® also stimulates the growth of DMBA-induced mammary tumors in Sprague Dawley rats. Female rats are given a 3% or 6% solution of Flor-Essence® or water alone for 23 weeks beginning at one day of age. DMBA is administered at 7 weeks of age to induce mammary tumors. At 16 weeks of age, control rats had a palpable mammary tumor incidence of 16% compared to 40% in the 3% and 27% in the 6% Flor-Essence® treated groups. At the end of the study 82% and 86% of rats treated with 3% and 6% Flor-Essence® had palpable tumors, respectively, compared to 71% in the control group. The average number of tumors observed was approximately 2-fold greater in the treated compared to control group. Preliminary results suggest that Flor-Essence® administration does not affect tumor development in mice with a mutated Her2/Neu gene. However administration during gestation has a persistent influence on body weight of the female offspring. Both Essiac® and Flor-Essence® have growth promoting effects on some breast cancer cells and Flor-Essence® promotes tumor growth in DMBA treated rats. These studies are important for the development of science-based recommendations for CAM use among women in our communities. This work was performed under the auspices of the U. S. Department of Energy by the University of California, Lawrence Livermore National Laboratory under Contract No. W-7405-Eng-48. The work was supported by the California Breast Cancer Research Program # 7IB-0003 and LDRD funding #02-FS-006. -
I've used flor-essence and love it but I was stage2b. I take it whenever I feel the need for a good detox (like after eating too much junky food for too many days in a row). I offer no advice. Good luck to you!
-
My mother was diagnosed 5.5 years ago at age 77 with stage 3c ovarian cancer . She had a complete hysterectomy and omentum removed. She still had residual cancer on her diaphram and colon. I did approximatly 100 hours of alternative cancer research as I knew nothing of cancer, it's causes, how to cure it, etc. I did oversee her treatment and I started her on organic food, juicing, half her body weight of pure water each day. She took essiac tea, MGN-3, Source of Life liquid vitamins. She started chemo as I researched it was very effective for ovarian. She reached clinical remission as of her CA-125 marker after 2 rounds of chemo. She stopped the chemo after 5 of 6 scheduled rounds. The Doctor's like to get their money's worth, but she was starting to have neuropathy in her fingers and toes. She is still here today, but we are now battling a primary DCIS that has metastisized to her spine. After an additional 100 hours of research I have her on a new protocol. I can answer your question about Essiac. It detoxifies the blood, and can have an effect on stopping angiogenisis of tumors. There is extensive info. on the web and in books about these herbs. It is inexpensive if you brew it yourself. Only 50cents or less per day. This treatment was almost passed by the canadian parliment as a bona fide cancer therapy. I would use it if I had cancer. Feel free to e-mail me with any questions at lisaathomas38@hotmail.com
-
Here is good info. on Essiac and peer reviewed test results https://essiac.readyhosting.com/peer_reviews.htm
-
Lisametoo,
thanks for the link. It's much stronger evidence than the studies I have found.
-
You are so welcome and Happy Thanksgiving. I have had a 5.5 year quest to find cures for cancer, and have investigated every substance available extensively. I have links to anything you could have an inquiry on. This is the best link for Essiac and the video's showing Ms. Caisse are amazing. Please everyone take time to look at this entire site, and you can order her original 4 herb formula from the Canadian Co. that owns it. http://www.essiac-canada.com/index.htm This site shows the videos: http://www.praxea.com/?gclid=CPvmrYrL748CFQ4lHgodgBIzFg#
-
I use liquid Essiac or Flor-essence because I don't like to spend time in the kitchen. They are both good for detoxing. Best wishes!
-
The Canadian Parliament thing was in the 1930s or 40s and it wasn't to pass it as a treatment, it was to let the woman practice medicine without a license province-wide (yes, I know she was a nurse). Since essiac is a combination of herbs you don't know for sure if you are getting what they say or even what is in it--no government regulation on that in the US. As long as you aren't allergic to any of the ingredients it probably won't hurt you. Whether or not it really does much else is unproven (clinically speaking).
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team